Exploiting the metabolic consequences of pten loss and akt/hexokinase 2 hyperactivation in prostate cancer: a new role for -tocotrienol

HIGHLIGHTS

  • who: Fabrizio Fontana and colleagues from the Department of Pharmacological and Biomolecular Sciences, Universitu00e0 degli Studi di Milano, Milan, Italy have published the article: Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for -Tocotrienol, in the Journal: (JOURNAL)
  • how: In the the authors we investigated whether u03b4-TT au03b4-TT well-known antitumorantitumor nutraceuIn thepresent presentstudy study investigated whether a well-known tical was able to specifically target the Akt/HK2-driven Warburg effect in PCa cells. nutraceutical was able to specifically target the Akt . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?